Clinical Group

Global Journal of Cancer Therapy

DOI

CC By

Advertise with us
Journal Information
  • Volume/IssueClick here
  • Review ProcessDouble Blind
    • Publication lead time3 - 4 weeks
    • Indexing statusYes; Purview
    • Manuscript Processing ChargesClick here
    • Submission ChargesNo
    • Waiver policy for APCYes
    • Language of Full TextEnglish
    • Full-text formats availablePDF, HTML
  • Show +
Best Practices
  • Type of LicenseCreative Commons
  • Open AccessYes; Policy
    • Does the author retain unrestricted copyright?Yes
    • Does the author retain publishing rights?Yes
    • Permanent article identifierDOI (Digital Object Identifier)
  • Show +
Publisher Information

Description

Global Journal of Cancer Therapy is an academic, open access and well-established journal which is keen to publishing high quality manuscripts focusing on cancer therapy. The peer reviewed journal which creates scientific platform is taking into an account on all the most recent and outstanding research articles, technical reports, regular book reviews, scientific data, le

Read more

Editorial Board

Christopher Xin Jie Wong
Centre for Heart Rhythm Disorders
Royal Adelaide Hospital
South Australia
c.wong@adelaide.edu.au
GJCT
Research Interest: Dr Wong’s Research Interests Focus On The Mechanisms, Clinical Treatment And Public Health Implications Of Cardiovascular Disease.
More Info.
Athanasios Papatsoris
Urology
Royal London Hospital
UK
agpapatsoris@yahoo.gr
GJCT

Research Interest: Endourology, Lithiasis, Laparoscopy, Prostate Cancer.

More Info.
Ana Livia Silva Galbiatti
Faculdade de Medicina de São José do Rio Preto
Brazil
analivia_sg@yahoo.com.br
GJCT

Research Interest: Head And Neck Cancer, Genetics, Molecular Biology, Cell Line, Chemoterapeutics, Genetic Polymorphisms


More Info.
Xingding Zhang
Assistant Professor
Diagnosis and Nanomedicine Engineering Technology Center
China
ading5@hotmail.com
GJCT

Research Interest: Autophagy and Apoptosis


More Info.
Karim Essani
Professor
Department of Biological Sciences
Western Michigan University
USA
karim.essani@wmich.edu
GJCT
Research Interest: Virus, Poxvirus, Tanapoxvirus, Virotherapy, Oncolytic viruses
More Info.
Muzafar Ahmad Macha
Department of Biochemistry
Molecular Biology University Nebraska Medical Center
USA
muzafar.macha@unmc.edu
GJCT

Research Interest : Animal handling: Oral cavity/pancreatic cancer orthotopic and subcutaneous xenograft models; Protein technology: Protein estimation, SDS PAGE, western blotting, 2D gel electrophoresis, Immunoprecipitation; Recombinant DNA technology: bacterial culture and preparation of competent cells; Cell culture technique: isolation of genomic plasmid/DNA/RNA isolation, PCR, RT-PCR, Real time PCR, Electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (CHIP), cell proliferation and viability assays, invasion and motility assay, scratch assay, immunocytochemistry, confocal laser scan microscopy, FACS analysis, ELISA, immunohistochemistry


More Info.
Letizia Polito
Assistant Professor
Department of Experimental
University of Bologna
Italy
letizia.polito@unibo.it
GJCT

Research Interest: The Scientific Activity Is Focused On Two Main Topics Concerning The Study Of Plant Toxins Known As Ribosome-Inactivating Proteins (Rips), And The Design And Testing In Vitro And In Vivo Of Immunotoxins For The Experimental Therapy Of Tumors And For The Immunosuppression.


More Info.
Edgar Selzer
Professor
Landesklinikum Wiener Neustadt
Medical University Vienna
Austria
eselze82@gmail.com
GJCT

Research Interest:Oncology, Radiotherapy, Radiobiology, Head And Neck Cancer; Anti-Cancer Drug Research


More Info.
Francisco Torrens
Associated Professor
Deparmenr of Biochemistry & Molecular Biology
Universidad de Murcia,
Spain
Francisco.Torrens@uv.es
GJCT

Research Interest: Theoretical Chemistry, Physical Chemistry, Mathematical Chemistry, Computational Chemistry, Molecular Modelling, Simulation, And Design, Computer-Aided Drug Design And Development, Molecular Graphics And Representation Of Molecular Properties.


More Info.
Julius Strauss
Associate Investigator
National Cancer Institute
Thomas Aquinas College
USA
julius.strauss@nih.gov
GJCT

Research Interest: Cancer Immunotherapies  Therapeutic Cancer Vaccines, Genitourinary Malignancies

More Info.
Varun Mittal
Hematology and Oncology
Albert Einstein Healthcare Network
USA
Varun.doc7@gmail.com
GJCT

Research Interest: Population Based Analysis of Cancer Database, Lung Carcinoma

More Info.
Wei Du
Hematology and Cancer Biology
Cincinnati Childrens Hospital Medical Center
USA
Wei.Du@cchmc.org
GJCT

Research Interest: Stem Cell Biology And Pathophysiology Of Bone Marrow Failure And Leukemia; Identifying And Targeting The Alternative Oxidative DNA-Damage Response Pathways Required For Cancer Progression; The Role Of A Major Proliferating Protein, Nucleophosmin (NPM) In Cancer Development


More Info.
Hidenari Nagai
Department of Internal Medicine
Toho University
Japan
hidenari@aol.com
GJCT

Research Interest:  I Am Interested In Strategy Of Hepatocellular Carcinoma And Especially I Am Interested In Host Immunity In Patients With Liver Cirrhosis And Hepatocellular Carcinoma.


More Info.
Peng Zhan
Associate Professor
Shandong University,
China
zhanpeng1982@163.com
GJCT

Research Interest: Discovery of Novel Antiviral, Anticancer and Neurodegenerative Diseases-Related Agents Based on The Rational Drug Design Approaches.


More Info.
Jose Maria Pereira de Godoy
Assistant Professor
Regional Medical School
egional Medical School, São José do Rio Preto
Brazil
godoyjmp@riopreto.com.br
GJCT
Research Interest: Breast CancerRehabilitationLymphedema  
More Info.
View more

Role of tumor heterogeneity in drug resistance

Published On: July 20, 2017 | Pages: 032 - 033

Author(s): Dhruv Kumar*
View Article

MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer

Published On: May 26, 2017 | Pages: 030 - 031

Author(s): Julius Strauss*
View Article

Angiosarcoma of the Scalp and Face: A Hard to Treat Tumor

Published On: April 15, 2017 | Pages: 026 - 029

Author(s): Jmour Omar*, Kochbati Lotfi , Ghith Sahar and Benna Farouk
View Article

The Promise of Disease Management in Greece

Published On: March 30, 2017 | Pages: 018 - 025

Author(s): Konstantinos Stamatiou, Richard Lacroix, Eleni Almpani, Konstantinos Katsanos, Georgios Tzitzikos and Maria Saridi*
View Article

Abrikossoff’s Tumour Mimicking a Neoplastic Tumour of the Breast: A Case Report

Published On: March 20, 2017 | Pages: 015 - 017

Author(s): Alassiri A*, Al Ali A, Vaysse C, Escourrou G, Vinet B and Rimailho J
View Article

The Role of Decavanadate in Anti- Tumour Activity

Published On: March 11, 2017 | Pages: 012 - 014

Author(s): M Aureliano*
View Article

Diagnosing HPV-Related Oropharyngeal Cancers: The Need to Speak a Common Language

Published On: March 07, 2017 | Pages: 008 - 011

Author(s): Daniela Russo#, Francesco Merolla#, Gennaro Ilardi*, Silvia Varricchio, Danila Caroppo, Virginia Napolitano, Massimo Mascolo and Stefania Staibano
View Article

Is it Time for the Introduction of Colostomy Free Survival in Rectal Cancer Patients

Published On: February 28, 2017 | Pages: 004 - 007

Author(s): Mostafa El Haddad*
View Article

Primary Spindle Cell Rhabdomyosarcoma of Prostate: A Case Report with Review of Literature

Published On: February 10, 2017 | Pages: 001 - 003

Author(s): Ram Nawal Rao*, Sanjay Kannaujia and Paramita Paul
View Article

The Paradoxes of Neoantigenes in Predicting Better Prognosis of Cancer Patients

Published On: December 30, 2016 | Pages: 030 - 031

Author(s): Rui-An Wang*, Qing-Guo Yan and Jian-Guo Shi
View Article
TOP